{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:23:21Z","timestamp":1768641801329,"version":"3.49.0"},"reference-count":97,"publisher":"Elsevier","isbn-type":[{"value":"9780323950572","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2022.12.002","type":"book-chapter","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:22:37Z","timestamp":1673364157000},"page":"423-444","source":"Crossref","is-referenced-by-count":3,"title":["The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD)"],"prefix":"10.1016","member":"78","reference":[{"issue":"12","key":"10.1016\/bs.apha.2022.12.002_bb0010","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.4049\/jimmunol.170.12.6266","article-title":"Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells","volume":"170","author":"Ariel","year":"2003","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0015","first-page":"231","article-title":"Expression of vascular endothelial growth factor in nasal polyp and chronic rhinosinusitis","volume":"11","author":"Azizzadeh Delshad","year":"2016","journal-title":"Iranian Journal of Pathology"},{"issue":"10209","key":"10.1016\/bs.apha.2022.12.002_bb0020","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): Results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00003495-200161050-00003","article-title":"Topical corticosteroids in nasal polyposis","volume":"61","author":"Badia","year":"2001","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/bs.apha.2022.12.002_bb0030","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s11306-012-0421-9","article-title":"Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues","volume":"8","author":"Balvers","year":"2012","journal-title":"Metabolomics"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/thx.39.7.500","article-title":"Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects","volume":"39","author":"Barnes","year":"1984","journal-title":"Thorax"},{"issue":"174","key":"10.1016\/bs.apha.2022.12.002_bb0040","doi-asserted-by":"crossref","first-page":"174ra126","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Science Translational Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0060","first-page":"1201","article-title":"15-lipoxygenase immunoreactivity in normal and in asthmatic airways","volume":"151","author":"Bradding","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2022.04.007","article-title":"Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease","volume":"150","author":"Buchheit","year":"2022","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0075","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0022-3565(25)11372-4","article-title":"Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the Guinea pig lung","volume":"260","author":"Bureau","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): A dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"10","key":"10.1016\/bs.apha.2022.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2007.02806.x","article-title":"Lipoxin A4 levels in asthma: Relation with disease severity and aspirin sensitivity","volume":"37","author":"Celik","year":"2007","journal-title":"Clinical and Experimental Allergy"},{"issue":"8","key":"10.1016\/bs.apha.2022.12.002_bb0090","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1535-7163.MCT-10-0173","article-title":"Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: The role of antiangiogenesis","volume":"9","author":"Chen","year":"2010","journal-title":"Molecular Cancer Therapeutics"},{"issue":"42","key":"10.1016\/bs.apha.2022.12.002_bb0095","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5 Pt 1","key":"10.1016\/bs.apha.2022.12.002_bb0100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"The American Review of Respiratory Disease"},{"issue":"11","key":"10.1016\/bs.apha.2022.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1046\/j.1365-2222.2002.01477.x","article-title":"Expression and activation of 15-lipoxygenase pathway in severe asthma: Relationship to eosinophilic phenotype and collagen deposition","volume":"32","author":"Chu","year":"2002","journal-title":"Clinical and Experimental Allergy"},{"issue":"21","key":"10.1016\/bs.apha.2022.12.002_bb0110","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2022.12.002_bb0115","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1073\/pnas.78.6.3887","article-title":"Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response","volume":"78","author":"Dahlen","year":"1981","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2022.12.002_bb0120","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1073\/pnas.80.6.1712","article-title":"Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4","volume":"80","author":"Dahlen","year":"1983","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5790","key":"10.1016\/bs.apha.2022.12.002_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi","volume":"288","author":"Dahlen","year":"1980","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.apha.2022.12.002_bb0130","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chemical Reviews"},{"issue":"9","key":"10.1016\/bs.apha.2022.12.002_bb0135","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1016\/S0021-9258(19)34105-5","article-title":"The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases","volume":"265","author":"DeWitt","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0140","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1073\/pnas.77.7.4354","article-title":"Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro","volume":"77","author":"Drazen","year":"1980","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/02770903.2018.1490754","article-title":"Depression symptoms and quality of life among individuals with aspirin-exacerbated respiratory disease","volume":"56","author":"Feldman","year":"2019","journal-title":"The Journal of Asthma"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.180.1.253","article-title":"Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor","volume":"180","author":"Fiore","year":"1994","journal-title":"The Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Advances in Nutrition"},{"issue":"8 Pt 1","key":"10.1016\/bs.apha.2022.12.002_bb0165","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/ajrccm.164.8.2102033","article-title":"Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma","volume":"164","author":"Gauvreau","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/ajrccm.159.1.9804030","article-title":"Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation","volume":"159","author":"Gauvreau","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9440(10)63937-5","article-title":"Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses","volume":"158","author":"Gronert","year":"2001","journal-title":"The American Journal of Pathology"},{"issue":"16","key":"10.1016\/bs.apha.2022.12.002_bb0180","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1158\/1078-0432.CCR-05-0733","article-title":"Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers","volume":"11","author":"Gross","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/bs.apha.2022.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaip.2017.04.035","article-title":"Smoking cessation as a possible risk factor for the development of aspirin-exacerbated respiratory disease in smokers","volume":"6","author":"Hayashi","year":"2018","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0195","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.09.019","article-title":"Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis","volume":"129","author":"Higashi","year":"2012","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0205","first-page":"158","article-title":"Cigarette smoking, cyclooxygenase-2 pathway and cancer","volume":"1815","author":"Huang","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0210","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaip.2019.02.037","article-title":"Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD","volume":"7","author":"Huang","year":"2019","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0215","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0220","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-Hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"key":"10.1016\/bs.apha.2022.12.002_bb0225","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/DDDT.S243053","article-title":"Dupilumab: Clinical efficacy of blocking IL-4\/IL-13 signalling in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Kariyawasam","year":"2020","journal-title":"Drug Design, Development and Therapy"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0230","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"issue":"10","key":"10.1016\/bs.apha.2022.12.002_bb0240","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"issue":"2 Pt 1","key":"10.1016\/bs.apha.2022.12.002_bb0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1164\/ajrccm.161.2.9902034","article-title":"Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients","volume":"161","author":"Kowalski","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0250","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-6749(03)01716-0","article-title":"Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients","volume":"112","author":"Kowalski","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.iac.2012.11.006","article-title":"Pathogenesis of aspirin-exacerbated respiratory disease and reactions","volume":"33","author":"Laidlaw","year":"2013","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0260","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"11","key":"10.1016\/bs.apha.2022.12.002_bb0265","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1164\/rccm.200905-0740OC","article-title":"Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis","volume":"180","author":"Lee","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2006.09.011","article-title":"Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease","volume":"119","author":"Lee","year":"2007","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0275","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/rccm.200410-1413OC","article-title":"Diminished lipoxin biosynthesis in severe asthma","volume":"172","author":"Levy","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2022.12.002_bb0280","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: Signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nature Immunology"},{"issue":"9","key":"10.1016\/bs.apha.2022.12.002_bb0285","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4)","volume":"8","author":"Levy","year":"2002","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0290","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1172\/JCI116738","article-title":"Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins","volume":"92","author":"Levy","year":"1993","journal-title":"The Journal of Clinical Investigation"},{"issue":"9146","key":"10.1016\/bs.apha.2022.12.002_bb0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(98)09019-9","article-title":"Leukotriene-receptor antagonists","volume":"353","author":"Lipworth","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb491","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"42","key":"10.1016\/bs.apha.2022.12.002_bb0300","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apha.2022.12.002_bb0305","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nature Structural Biology"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0310","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.21037\/jtd.2018.03.02","article-title":"Lipoxin A4 regulates PM2.5-induced severe allergic asthma in mice via the Th1\/Th2 balance of group 2 innate lymphoid cells","volume":"10","author":"Lu","year":"2018","journal-title":"Journal of Thoracic Disease"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0315","first-page":"449","article-title":"Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro","volume":"126","author":"Marom","year":"1982","journal-title":"The American Review of Respiratory Disease"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0320","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"11","key":"10.1016\/bs.apha.2022.12.002_bb0325","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1398-9995.2001.00913.x","article-title":"Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma","volume":"56","author":"Mita","year":"2001","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/bs.apha.2022.12.002_bb0330","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-3083.1990.tb03190.x","article-title":"Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils","volume":"32","author":"Morita","year":"1990","journal-title":"Scandinavian Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/CMR.16.3.517-533.2003","article-title":"Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes","volume":"16","author":"Noverr","year":"2003","journal-title":"Clinical Microbiology Reviews"},{"issue":"11","key":"10.1016\/bs.apha.2022.12.002_bb0340","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.apha.2022.12.002_bb0345","article-title":"Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis","author":"Picado","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/bs.apha.2022.12.002_bb0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/rccm.200801-061OC","article-title":"Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma","volume":"178","author":"Planaguma","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0355","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0360","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/eji.201343316","article-title":"Lipoxin A(4) modulates adaptive immunity by decreasing memory B-cell responses via an ALX\/FPR2-dependent mechanism","volume":"44","author":"Ramon","year":"2014","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0365","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","article-title":"The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages","volume":"161","author":"Rossi","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"4819","key":"10.1016\/bs.apha.2022.12.002_bb0370","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.apha.2022.12.002_bb0375","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3003.2000.16a08.x","article-title":"Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics","volume":"16","author":"Sanak","year":"2000","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/bs.apha.2022.12.002_bb0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.prostaglandins.2014.05.002","article-title":"Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins","volume":"113\u2013115","author":"Schebb","year":"2014","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0385","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaip.2017.10.011","article-title":"Dietary fatty acid modification for the treatment of aspirin-exacerbated respiratory disease: A prospective pilot trial","volume":"6","author":"Schneider","year":"2018","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"18","key":"10.1016\/bs.apha.2022.12.002_bb0390","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1073\/pnas.87.18.6974","article-title":"Inhibition of eicosanoid biosynthesis by glucocorticoids in humans","volume":"87","author":"Sebaldt","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.12.002_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.695815","article-title":"Aspirin actions in treatment of NSAID-exacerbated respiratory disease","volume":"12","author":"Sehanobish","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"17","key":"10.1016\/bs.apha.2022.12.002_bb0400","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0405","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-291X(84)91486-4","article-title":"Trihydroxytetraenes: A novel series of compounds formed from arachidonic acid in human leukocytes","volume":"118","author":"Serhan","year":"1984","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0410","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI114503","article-title":"Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro","volume":"85","author":"Serhan","year":"1990","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/bs.apha.2022.12.002_bb0415","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/alr.22418","article-title":"Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients","volume":"9","author":"Shah","year":"2019","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0420","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaci.2007.11.018","article-title":"Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis","volume":"121","author":"Small","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0425","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaci.2020.04.031","article-title":"Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease","volume":"147","author":"Stevens","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0430","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2022.12.002_bb0435","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0440","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1039\/C9RA08860A","article-title":"Unraveling how the Gly526Ser mutation arrests prostaglandin formation from arachidonic acid catalyzed by cyclooxygenase-2: A combined molecular dynamics and QM\/MM study","volume":"10","author":"Suner-Rubio","year":"2020","journal-title":"RSC Advances"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0445","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1164\/ajrccm.153.2.8564099","article-title":"Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma","volume":"153","author":"Szczeklik","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 2","key":"10.1016\/bs.apha.2022.12.002_bb0450","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1136\/thorax.55.suppl_2.S42","article-title":"Clinical features and diagnosis of aspirin induced asthma","volume":"55","author":"Szczeklik","year":"2000","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/bs.apha.2022.12.002_bb0455","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE investigators. European network on aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"The European Respiratory Journal"},{"issue":"6 Pt 1","key":"10.1016\/bs.apha.2022.12.002_bb0460","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9","key":"10.1016\/bs.apha.2022.12.002_bb0465","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.185.9.1693","article-title":"Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors","volume":"185","author":"Takano","year":"1997","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.apha.2022.12.002_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.06.016","article-title":"The role of omalizumab in NSAID-exacerbated respiratory disease: A narrative review","author":"Taniguchi","year":"2022","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"4 Pt 1","key":"10.1016\/bs.apha.2022.12.002_bb0475","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/ajrccm.154.4.8887574","article-title":"Persistent airway eosinophilia after leukotriene (LT) D4 administration in the Guinea pig: Modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody","volume":"154","author":"Underwood","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1016\/bs.apha.2022.12.002_bb0480","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2022.12.002_bb0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacological Reviews"}],"container-title":["Advances in Pharmacology","Bioactive Lipid Mediators in Cardiopulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:21:31Z","timestamp":1753338091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358922000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323950572"],"references-count":97,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2022.12.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}